Document is current
Any future updates will be listed below
-
Authors
Zhu, Ziyu
Lei, Du https://orcid.org/0000-0002-3503-3692
Qin, Kun
Tallman, Maxwell J.
Patino, L. Rodrigo
Fleck, David E.
Gong, Qiyong https://orcid.org/0000-0002-5912-4871
Sweeney, John A. https://orcid.org/0000-0003-1752-2828
DelBello, Melissa P.
McNamara, Robert K.
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81820108018, 82027808)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH097818, R01MH097818)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
- License Information
-
More Information
Article History
Received: 18 April 2023
Revised: 31 October 2023
Accepted: 13 November 2023
First Online: 30 November 2023
Competing interests
: M.P.D. receives research support from NIH, PCORI, Acadia, Alkermes, Allergan, Janssen, Johnson and Johnson, Lundbeck, Otsuka, Pfizer, Sage, Sunovion, and Vanda. She is also a consultant, on the advisory board, or has received honoraria for speaking for Alkermes, Allergan, Assurex, CMEology, Janssen, Johnson and Johnson, Lundbeck, Myriad, Neuronetics, Otsuka, Pfizer, Sage, Sunovion, and Supernus. R.K.M. has received research support from Martek Biosciences Inc, Royal DSM Nutritional Products, LLC, Inflammation Research Foundation, Ortho-McNeil Janssen, AstraZeneca, Eli Lilly, NARSAD, and national institutes of health (NIH), and previously served on the scientific advisory board of the Inflammation Research Foundation. The remaining authors do not have disclosures. LRP receives research funding from NIH, PCORI, Abbvie, Allergan, Janssen, Johnson and Johnson, Lundbeck, Lilly, Otsuka, Pfizer, and Sunovion.
